AranoffG.R., SloanR.S., LuftP.C.Pharmacocinetics of Moxalactam in patients with normal and impaired renal function.J Infect Dis1982; 145: 365–9.
2.
BarzaM., TallyP.P., JacobusN.V.In vitro activity of L Y 127935 (Moxalactam).Antimicrob Agents Chemother1979; 16: 287–92.
3.
LeroyA., HumbertG., PillastreJ.P.Pharmacokinetics of Moxalactam in subjects with normal and impaired renal function.Antimicrob Agents Chemother1981; 19: 1965–71.
4.
WeaverS.S., LeblancB.M., BodeyG.P.In vitro studies of 1. Oscacephalosporin (L Y 127935), a new Beta-lactam antibiotic.Antimicrob Agents Chemother1980; 17: 92–5.
5.
TabouretA.M., SinglasE., BoutronH.Moxalactam pharmacokinetics during chronic ambulatory peritoneal dialysis. II World conference on clinical pharmacology and therapeutics. Washington, D.C. July 31–August 5. 1983.
